On August 5, the U.S. Food and Drug Administration (FDA) named Cadence the second participant in its TEMPO pilot program for HypertensionOS, a software device that generates protocol-bound medication-…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has weighed in on whether AI scribes are medical devices, a decision that could shape how these tools are regulated in healthcare. The…
The FDA named Dexcom the first participant in its TEMPO pilot on July 22, 2026, pairing real-world evidence collection with CMS's ACCESS payment model to support wearable diagnostic AI. Dexcom's devic…
A developer built a time-series forecasting engine using Temporal Convolutional Networks (TCN) and PyTorch Lightning to predict blood glucose spikes from Continuous Glucose Monitor (CGM) data. The sys…